Connecticut pulmonology practices face a revenue cycle environment that is more demanding than the state’s small size might suggest. The combination of Aetna’s sophisticated utilization management, UnitedHealthcare’s growing Connecticut presence, a complex Medicaid managed care structure, academic medical center billing dynamics, and one of the highest costs of living in the country creates a billing environment where process gaps translate into revenue losses at rates that exceed national benchmarks.
For Connecticut pulmonology practices — whether independent practices in Hartford or New Haven, hospital-affiliated groups in Bridgeport or Waterbury, or academic practices associated with Yale or UConn — tightening the revenue cycle means addressing specific, identifiable gaps in billing workflows that are creating preventable revenue loss. It does not require a complete RCM overhaul. It requires understanding exactly where the revenue is going and implementing the targeted fixes that stop the leak.
This post is a practical guide to revenue cycle improvement for Connecticut pulmonology practices. It covers the most impactful areas for improvement — front-end eligibility and authorization, documentation quality, denial management, payment accuracy, and performance measurement — with specific attention to the Connecticut payer environment that shapes each of these areas.
Why Connecticut Pulmonology Practices Lose Revenue They Should Not Lose
Revenue leakage in Connecticut pulmonology practices follows patterns that are predictable once you know what to look for. The practices that struggle most with revenue cycle performance are not typically making egregious billing errors — they are making process errors that compound quietly over time. Authorization gaps that seem minor until they aggregate into write-offs. Documentation that is clinically complete but billing-incomplete. Denial worklists that grow faster than they are worked. Payments accepted without comparison to contracted rates.
The Connecticut-specific factor that amplifies these common problems is the payer environment. Aetna applies more rigorous medical necessity review to pulmonary services in Connecticut than most practices are prepared for. UnitedHealthcare’s Connecticut book of business includes a high proportion of Fairfield County patients with premium commercial coverage — and premium coverage comes with premium utilization management scrutiny. HUSKY Health managed care adds MCO routing complexity that creates eligibility-related denials for practices that do not verify enrollment through the CMAP portal.
The practices that consistently outperform in Connecticut’s revenue cycle environment are not doing more work. They have closed the gaps that turn earned revenue into write-offs — and they have the metrics to prove it.
Tightening Area One: Front-End Eligibility and Authorization
The most leveraged investment in Connecticut pulmonology revenue cycle improvement is front-end eligibility and authorization accuracy. Every denial that originates from an eligibility error or an authorization gap was created before billing touched the claim. Every fix that happens at the front end prevents a denial that would otherwise require rework, appeals, and potentially write-off weeks later.
Eligibility Verification That Catches What Standard Checks Miss
Standard eligibility verification confirms that a patient has active coverage with the payer identified on their insurance card. For Connecticut pulmonology practices, that is necessary but not sufficient. The verification must also confirm which specific Aetna product the patient is enrolled in — fully insured commercial, ASO, Medicare Advantage, or Aetna Better Health — because each product has different authorization requirements, different appeal rights, and potentially different fee schedules.
For HUSKY Health patients, eligibility verification must confirm MCO enrollment through the CMAP portal. A positive HUSKY Health eligibility response that does not identify the specific MCO — Aetna Better Health, Anthem HealthKeepers Plus, or Community Health Network — is insufficient for claim routing. Claims submitted to HUSKY fee-for-service for MCO-enrolled patients will deny, and if the denial is not identified and corrected within the MCO’s timely filing window, the revenue is permanently lost.
For patients with Medicare Advantage coverage — growing in Connecticut as the state’s senior population increases and Medicare Advantage penetration rises — eligibility verification must confirm the specific Medicare Advantage plan and confirm that the practice is in-network for that plan. Medicare Advantage plans in Connecticut include Aetna Medicare Advantage, UnitedHealthcare AARP Medicare Advantage, ConnectiCare Medicare Advantage, and others, each with different networks and prior authorization requirements. A practice that is in-network for Aetna commercial may not be in-network for Aetna Medicare Advantage, and a claim submitted without network verification may generate an out-of-network denial that should have been caught at scheduling.
Authorization Workflows Built for Connecticut’s Payer Mix
Authorization workflows for Connecticut pulmonology practices must distinguish between Aetna commercial, Aetna ASO, Aetna Medicare Advantage, Aetna Better Health, UnitedHealthcare commercial, UnitedHealthcare Medicare Advantage, ConnectiCare commercial, ConnectiCare Medicare Advantage, and HUSKY Health MCOs — because the authorization requirements for pulmonary procedures differ across these plans in ways that a single authorization checklist cannot accommodate.
The authorization matrix that supports this differentiation must be maintained actively. Aetna updates its Clinical Policy Bulletins regularly. UnitedHealthcare updates its Coverage Determination Guidelines. ConnectiCare updates its coverage policies. HUSKY Health MCOs update their coverage policies when Connecticut Medicaid policy changes. A practice whose authorization matrix has not been reviewed in six months is operating on outdated information for at least some of the payer relationships it manages.
Authorization expiration tracking is the other front-end workflow gap that creates preventable Connecticut denials. Aetna’s authorizations for outpatient pulmonary procedures are typically valid for 60 to 90 days. When a procedure is rescheduled after the authorization window closes, the claim will deny for authorization not valid on date of service. A day-before appointment confirmation that includes authorization expiration verification — and triggers a renewal request for expired authorizations — eliminates this denial category at a cost of minutes per appointment.
Tightening Area Two: Clinical Documentation Quality
Documentation quality is the most direct determinant of denial probability for pulmonary services in Connecticut. Aetna’s medical necessity review for pulmonary procedures compares the clinical documentation against the criteria in its Clinical Policy Bulletins. Documentation that meets those criteria results in payment. Documentation that does not results in denial — regardless of the clinical appropriateness of the service.
The High-Denial Procedure Categories
The procedure categories with the highest denial rates for Connecticut pulmonology practices — and therefore the highest documentation improvement impact — are pulmonary function testing, sleep diagnostics, bronchoscopy and advanced bronchoscopic procedures, pulmonary rehabilitation, and biologic therapy for severe asthma and COPD.
For each of these categories, the documentation gap that drives Aetna denials is consistent: the clinical note establishes what was done but not why it was done in a way that addresses Aetna’s specific medical necessity criteria. A note that documents spirometry results without explaining the clinical question the testing was intended to answer does not meet Aetna’s PFT documentation standard. A sleep study order that notes snoring without the structured pre-test probability assessment Aetna requires does not support medical necessity under Aetna’s sleep diagnostic policy.
Documentation templates built around Aetna’s specific criteria — and used consistently by all providers in the practice — are the most efficient documentation quality intervention available. They do not add significant clinical documentation burden. They redirect the documentation effort that already exists toward the elements that matter for medical necessity review. And they produce documentation that is defensible not just at initial claim review but at appeal and at post-payment audit.
Provider-Level Documentation Variability: The Hidden Risk Factor
Multi-provider Connecticut pulmonology practices face a documentation quality risk that single-provider practices do not: provider-level variability. When different providers document the same procedure type in materially different ways — one with detailed clinical rationale, another with a brief note and a diagnosis code — the practice presents an inconsistent audit profile that increases the probability of a post-payment review.
Aetna’s post-payment review process can identify provider-level documentation variability within a practice. A practice where one provider’s bronchoscopy notes consistently include the elements Aetna requires and another provider’s notes do not creates a situation where the second provider’s claims are systematically more vulnerable to post-payment review findings. When those findings generate a recoupment demand, the practice’s revenue from the first provider does not offset the liability from the second.
Quarterly internal documentation audits by provider — reviewing a sample of each provider’s notes for high-denial procedure categories against Aetna’s criteria — identify variability before it becomes an audit finding. Providers with consistent documentation gaps receive targeted feedback and, if necessary, additional training. The audit results are trended over time so that improvement is measurable and regression is caught early.
Tightening Area Three: Denial Management and Recovery
Connecticut pulmonology practices that have invested in front-end prevention and documentation quality will still generate denials — every practice does. The question is whether those denials are worked fast enough, by the right people, with the right approach, to maximize recovery. In Connecticut’s payer environment, the answer to that question determines whether the denial inventory becomes a revenue recovery operation or a write-off accumulator.
Denial Age: The Financial Decay Curve
The financial mathematics of denial aging apply in Connecticut as they apply everywhere: denials worked within seven days of receipt recover at 85 to 92 percent. Denials worked at 31 to 60 days recover at 50 to 62 percent. After 60 days, recovery probability falls to 28 to 40 percent. And 65 percent of denials nationally are never resubmitted at all.
Connecticut’s payer-specific appeal windows create additional urgency. Aetna’s standard appeal window for commercial claims is 180 days from the date of denial — relatively generous. But HUSKY Health MCO appeal windows may be as short as 60 days, and ConnectiCare’s appeal timelines vary by plan type. A denial worklist that treats all denials with equal urgency — first in, first out — will allow short-window MCO denials to age past the appeal deadline while longer-window commercial denials are worked first.
Denial triage by payer appeal deadline — not by receipt date or claim value — is the operational change that prevents appeal window failures. HUSKY Health MCO denials with 60-day windows get worked within 10 days of receipt. Aetna commercial denials with 180-day windows can be worked within 30 days without appeal window risk. The triage decision is informed by the payer’s specific deadline, not by a general urgency assessment.
Building Connecticut-Specific Appeal Strategies
Appeals against Aetna denials in Connecticut succeed when they are built around Aetna’s Clinical Policy Bulletins. The appeal letter must identify the specific CPB governing the denied service, cite the specific criteria the service meets, and provide clinical documentation that demonstrates that meeting. An appeal that argues the general clinical appropriateness of a bronchoscopy without referencing Aetna’s bronchoscopy CPB and the specific criteria the procedure satisfies will not succeed at the rate that a CPB-specific appeal does.
Connecticut’s external review process — available through the Connecticut Insurance Department for Aetna fully insured product denials — is a meaningful recovery pathway for medical necessity denials where the clinical evidence base is strong. Pulmonary practices that pursue external review for appropriate Aetna denials — biologic therapy denials, advanced bronchoscopy denials, pulmonary rehabilitation denials — recover revenue that internal appeal processes would not have produced. Connecticut’s IRO overturn rate for pulmonary specialty denials is worth tracking and factoring into appeal strategy decisions.
For Aetna ASO plan denials — where Connecticut external review is not available because ERISA governs self-funded plans — the appeal strategy must be grounded in the specific plan documents and ERISA appeal procedures. Practices that inadvertently pursue Connecticut external review for ASO plan denials will find the external review rejected for lack of jurisdiction, wasting time and the internal appeal window.
Tightening Area Four: Payment Accuracy Monitoring
Connecticut’s high commercial reimbursement rates make payment accuracy monitoring particularly valuable. Aetna’s contracted rates for pulmonary procedures in Connecticut are among the highest in the Northeast. When those rates are not being paid correctly — because of bundling adjustments, fee schedule discrepancies, or payer errors in modifier or place-of-service application — the per-claim underpayment is larger than it would be in lower-reimbursement markets.
Payment variance monitoring requires a current, payer-specific fee schedule loaded in the billing system that allows each payment to be compared against the contracted rate for the procedure and the payer. Without that baseline, underpayments are invisible — the payment posts, the claim closes, and the revenue gap becomes permanent. With it, systematic underpayment patterns surface as variance reports that can be disputed within Aetna’s and UHC’s prompt pay dispute timelines.
The most common underpayment patterns in Connecticut pulmonology practices involve Aetna bundling adjustments that reduce payment below the contracted rate for separately billable procedure components, UnitedHealthcare fee schedule applications that do not reflect the current contracted rate following a contract renewal, and ConnectiCare payment errors on complex procedure codes where the payer’s claims processing system applies an incorrect reduction.
Connecticut’s prompt pay law — Conn. Gen. Stat. § 38a-816 — requires commercial insurers to pay clean claims within 45 days of receipt for paper claims and 30 days for electronic claims, with interest penalties for late payment. Practices that track payment timing against these statutory deadlines and pursue interest on late payments are collecting revenue that practices without a prompt pay monitoring program leave uncollected.
Tightening Area Five: Revenue Cycle Performance Measurement
You cannot tighten what you cannot measure. Connecticut pulmonology practices that report only aggregate revenue cycle metrics — overall denial rate, overall days in AR, overall collection rate — are managing their billing performance with insufficient resolution to identify and address the specific gaps that are driving revenue loss.
The metrics that matter for Connecticut pulmonology revenue cycle improvement are payer-specific: denial rate by payer and by procedure category, average denial age by payer, appeal success rate by payer and by denial reason code, days in AR by payer, and payment variance rate by procedure and payer. These metrics reveal the patterns that aggregate metrics obscure. They point directly to where the workflow changes will have the most impact.
For Connecticut practices, the most revealing metrics are typically Aetna-specific: Aetna denial rate for PFTs, Aetna denial rate for sleep diagnostics, Aetna appeal success rate by denial reason code, and Aetna payment variance rate for bronchoscopy and advanced procedures. These metrics together paint a picture of the practice’s specific relationship with its largest and most demanding commercial payer — and they identify exactly where the intervention points are.
Monthly reporting of payer-specific metrics to practice leadership — not just to the billing department — creates organizational visibility into revenue cycle performance that drives resource allocation decisions. When practice leadership can see that Aetna bronchoscopy denials have increased 20 percent quarter over quarter, they can authorize the documentation template update and the authorization workflow change needed to address it. When that data lives only in a billing worklist, it is invisible to everyone with the authority to resource the fix.
The Connecticut Revenue Cycle Improvement Roadmap
A Connecticut pulmonology revenue cycle improvement initiative should follow a sequenced roadmap that addresses the highest-impact gaps first and builds on each improvement:
- Month 1–2: AR review and baseline measurement. Establish current denial rates by payer and procedure, average denial age, appeal success rates, and payment variance rates. This creates the baseline against which improvement is measured and identifies the highest-priority gaps.
- Month 2–3: Front-end workflow upgrades. Implement Aetna product type identification at eligibility verification, CMAP-based HUSKY Health MCO enrollment verification, authorization matrix update and quarterly review process, and authorization expiration tracking.
- Month 3–4: Documentation quality improvement. Deploy documentation templates for high-denial procedure categories built around Aetna’s Clinical Policy Bulletin criteria. Conduct provider training on medical necessity documentation standards. Begin quarterly documentation audits by provider.
- Month 4–5: Denial management restructuring. Implement denial triage by payer appeal deadline. Build Aetna-specific and HUSKY-specific appeal templates for the most common denial categories. Begin tracking appeal success rates by payer and denial reason code.
- Month 5–6: Payment accuracy monitoring. Load current Aetna, UHC, and ConnectiCare contracted rates into the billing system. Implement payment variance monitoring with monthly reporting. Begin disputing identified underpayments within prompt pay timelines.
- Month 6 onward: Performance measurement and continuous improvement. Monthly reporting of payer-specific metrics to practice leadership. Quarterly authorization matrix reviews. Annual documentation template updates against current Aetna CPBs. Tracking of revenue cycle performance trends against the baseline established in Month 1.
What Tightening the Revenue Cycle Actually Produces
Connecticut pulmonology practices that implement this roadmap consistently report measurable improvements across the key revenue cycle metrics within six to twelve months: lower Aetna denial rates for high-scrutiny procedure categories, higher appeal success rates driven by CPB-specific appeal strategies, reduced denial aging as triage processes accelerate high-priority claim resolution, and identified underpayments recovered through payment variance monitoring.
The financial impact varies by practice size and starting point. A Connecticut pulmonology practice with three providers, significant Aetna volume, and a current denial rate of 12 percent for pulmonary procedures that improves to 6 percent through documentation and authorization workflow changes is recovering approximately 6 percent of collectible revenue — revenue that was earned and billed but being written off. Depending on annual billings, that represents tens of thousands to hundreds of thousands of dollars annually in recovered revenue.
The practices that do not pursue this improvement are not standing still. Their denial rates and write-off patterns are accumulating while the payer environment becomes more demanding. Aetna’s utilization management in Connecticut will not become less rigorous. HUSKY Health’s MCO structure will not become simpler. The practices that build the workflows to manage this environment effectively now are protecting revenue that their competitors are losing.
How PulmoCare RCM Tightens the Revenue Cycle for Connecticut Practices
PulmoCare RCM works exclusively with pulmonary and critical care practices. Our Connecticut revenue cycle improvement program follows the roadmap described in this post — starting with an AR review that establishes the baseline, identifying the specific gaps driving revenue loss in your practice’s payer mix, and implementing the workflow changes that close them.
Our Connecticut-specific knowledge covers Aetna’s Clinical Policy Bulletins and authorization requirements across all Aetna product lines, UnitedHealthcare’s Connecticut coverage policies, ConnectiCare’s billing requirements, and HUSKY Health MCO enrollment and authorization requirements. We bring that knowledge to your practice’s specific billing challenges — not a generic RCM framework that does not account for Connecticut’s payer environment.
If your Connecticut pulmonology practice is ready to understand exactly where its revenue is going and implement the fixes that stop the loss, reach out to PulmoCare RCM for a complimentary AR review and revenue cycle assessment. The first step is making the invisible visible.